ArticleFrontiers in oncology2026
Case report: A rare case of gelatinous pericardial effusion in a COVID-19 positive breast cancer patient.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pericardial effusion can occur as a complication of breast cancer and coronavirus disease (COVID-19). However, the specific characteristics of pericardial fluid in patients concurrently experiencing both conditions remain poorly understood. Case summary: This report describes a 52-year-old woman with a history of hypothyroidism, diabetes mellitus, and breast cancer who developed recurrent pericardial effusion complicated by cardiac tamponade following COVID-19 infection. The patient initially underwent pericardiocentesis and subsequently required pericardiectomy. Notably, the pericardial fluid obtained during pericardiocentesis exhibited a distinctive gelatinous appearance, a feature not previously described in association with breast cancer or COVID-19. Conclusion: This case highlights the potential for unique interactions between breast cancer and COVID-19, particularly in the development of pericardial effusions with unusual characteristics and a gelatinous appearance. Further studies are warranted to elucidate the underlying mechanisms and clinical implications of this association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.